Search
for
Sort by
Research 361–390 of 1000+
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Emerging treatments in alopecia
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- Alopecia areata: recognition, diagnosis and management
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- Deuruxolitinib for Alopecia Areata.
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Tofacitinib in the Management of Alopecia Universalis
- Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Successful Treatment of Canities Subita with Baricitinib
- Targeted immunotherapy for hair regrowth and regeneration
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Evaluating Scarring Alopecia Therapies from the Patient Perspective: Knowledge, Barriers to Care, and Treatment Satisfaction
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Studi Molecular Docking Aktivitas Anti Alopecia pada Senyawa yang Terkandung dalam Daun Dadap Serep (Erythrina subumbrans (Hassk.) Merrill)
- Ritlecitinib: First Approval
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report